Fosun Wanbang (Jiangsu) Pharmaceutical Group Co.,Ltd.
Fosun Wanbang-We are committed to health with heart
Fosun IMC focuses on diabetes and has established core competitive advantages in R&D, production and sales in the fields of "four highs and one antibody" (hyperglycemia, hypertension, hyperlipidemia, hyperuricemia, and anti-tumor). In 2020, the company ranked first in market share for seven categories (IQVIA data), and 13 products had annual sales of over 100 million.
- Type
- Manufacturer
- Location
- Xuzhou/Jiangsu, China
- Website
- https://www.chinawanbang.com
- Categories
- Farmaceutische productie
Listed in a source registry
Verified facts
- corporate-mail-on-domain (green), checked 2026-08-08 Mail server of the company domain
- sanctions-clear (green), checked 2026-08-08 OpenSanctions
- lei-lapsed (amber), checked 2026-08-08 GLEIF
- debarment-clear (green), checked 2026-08-08 OpenSanctions
- domain-registered (green), checked 2026-08-08 Domain registry record
Import rules for these goods
- Medicines imported into the EU must come from a site holding an EU GMP certificate, and the importer needs a manufacturing/import authorisation. European Medicines Agency (GMP)